• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用慢性阻塞性肺病加重工具(EXACT)检测和严重程度分级 COPD 加重。

Detection and severity grading of COPD exacerbations using the exacerbations of chronic pulmonary disease tool (EXACT).

机构信息

University College London, London, UK.

出版信息

Eur Respir J. 2014 Mar;43(3):735-44. doi: 10.1183/09031936.00110913. Epub 2013 Aug 29.

DOI:10.1183/09031936.00110913
PMID:23988767
Abstract

Uncertainty exists over the ability of the exacerbations of chronic pulmonary disease tool (EXACT) patient-reported outcome diary to quantify exacerbation severity and frequency. To clarify this, we investigated the ability of the EXACT to assess severity of exacerbations and examined the relationship between exacerbations diagnosed using London chronic obstructive pulmonary disease (COPD) cohort diary cards, physician review and symptom-defined events using the EXACT. 58 patients enrolled in the London Chronic Obstructive Pulmonary Disease (COPD) cohort prospectively completed the EXACT during 128 cohort diary card-defined exacerbations between January 2010 and April 2012. Mean ± sd EXACT scores increased from 42.6 ± 8.6 at baseline to 48.0 ± 8.6 at exacerbation onset (p<0.001), and rose further to a maximum score of 54.1 ± 8.9. Maximum EXACT scores were significantly higher in treated than untreated events. Time taken for EXACT scores to return to baseline was significantly related to symptom recovery time as judged by London COPD cohort diary cards, and to peak expiratory flow rate recovery. ∼50% of both diary card-defined and healthcare utilisation exacerbations crossed the EXACT event threshold. However, only 27.9% of diary card-defined and 34.6% of healthcare utilisation exacerbations fully met the criteria for an EXACT event. Patients exhibited smaller rises in the EXACT score at exacerbation as baseline disease severity increased. The EXACT is an effective method of evaluating chronic obstructive pulmonary disease exacerbation severity. However, concerns remain about the ability of the EXACT to accurately detect exacerbations.

摘要

在量化慢性肺病加重(EXACT)患者报告结果日记的加重严重程度和频率的能力方面存在不确定性。为了阐明这一点,我们研究了 EXACT 评估加重严重程度的能力,并检查了使用 EXACT 诊断的加重与伦敦慢性阻塞性肺病(COPD)队列日记卡、医生审查和症状定义事件之间的关系。58 名患者前瞻性地参加了伦敦慢性阻塞性肺病(COPD)队列,在 2010 年 1 月至 2012 年 4 月期间完成了 128 次队列日记卡定义的加重事件。EXACT 评分的平均值±标准差从基线时的 42.6±8.6增加到加重开始时的 48.0±8.6(p<0.001),并进一步升高到 54.1±8.9 的最大值。在治疗过的事件中,EXACT 评分的最大值明显高于未治疗的事件。EXACT 评分恢复到基线所需的时间与伦敦 COPD 队列日记卡判断的症状恢复时间以及呼气峰流速恢复显著相关。约 50%的日记卡定义和医疗保健利用的加重事件跨越了 EXACT 事件阈值。然而,只有 27.9%的日记卡定义和 34.6%的医疗保健利用加重事件完全符合 EXACT 事件的标准。随着基线疾病严重程度的增加,患者在加重时 EXACT 评分的升高幅度较小。EXACT 是评估慢性阻塞性肺病加重严重程度的有效方法。然而,仍然存在对 EXACT 准确检测加重的能力的担忧。

相似文献

1
Detection and severity grading of COPD exacerbations using the exacerbations of chronic pulmonary disease tool (EXACT).使用慢性阻塞性肺病加重工具(EXACT)检测和严重程度分级 COPD 加重。
Eur Respir J. 2014 Mar;43(3):735-44. doi: 10.1183/09031936.00110913. Epub 2013 Aug 29.
2
Usefulness of the Chronic Obstructive Pulmonary Disease Assessment Test to evaluate severity of COPD exacerbations.慢性阻塞性肺疾病评估测试在评估 COPD 加重严重程度中的作用。
Am J Respir Crit Care Med. 2012 Jun 1;185(11):1218-24. doi: 10.1164/rccm.201110-1843OC. Epub 2012 Jan 26.
3
Relationship between frequency, length, and treatment outcome of exacerbations to baseline lung function and lung density in alpha-1 antitrypsin-deficient COPD.α1-抗胰蛋白酶缺乏型 COPD 患者加重频率、持续时间与肺功能和肺密度基线间的关系。
Int J Chron Obstruct Pulmon Dis. 2012;7:789-96. doi: 10.2147/COPD.S31797. Epub 2012 Nov 27.
4
Standardizing measurement of chronic obstructive pulmonary disease exacerbations. Reliability and validity of a patient-reported diary.标准化慢性阻塞性肺疾病加重的测量。患者报告日记的可靠性和有效性。
Am J Respir Crit Care Med. 2011 Feb 1;183(3):323-9. doi: 10.1164/rccm.201005-0762OC. Epub 2010 Sep 2.
5
Impact of Prolonged Exacerbation Recovery in Chronic Obstructive Pulmonary Disease.慢性阻塞性肺疾病中延长的急性加重期恢复的影响
Am J Respir Crit Care Med. 2015 Oct 15;192(8):943-50. doi: 10.1164/rccm.201412-2269OC.
6
A longitudinal assessment of sleep variables during exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重期睡眠变量的纵向评估。
Chron Respir Dis. 2015 Nov;12(4):299-304. doi: 10.1177/1479972315587517. Epub 2015 May 31.
7
Frequency of exacerbations in patients with chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.慢性阻塞性肺疾病患者的加重频率:SPIROMICS 队列分析。
Lancet Respir Med. 2017 Aug;5(8):619-626. doi: 10.1016/S2213-2600(17)30207-2. Epub 2017 Jun 28.
8
Exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病的急性加重
Respir Care. 2003 Dec;48(12):1204-13; discussion 1213-5.
9
The chronic obstructive pulmonary disease assessment test improves the predictive value of previous exacerbations for poor outcomes in COPD.慢性阻塞性肺疾病评估测试提高了既往加重对慢性阻塞性肺疾病不良结局的预测价值。
Int J Chron Obstruct Pulmon Dis. 2015 Nov 30;10:2571-9. doi: 10.2147/COPD.S91163. eCollection 2015.
10
Association between lung function and exacerbation frequency in patients with COPD.COPD 患者肺功能与加重频率的相关性。
Int J Chron Obstruct Pulmon Dis. 2010 Dec 9;5:435-44. doi: 10.2147/COPD.S13826.

引用本文的文献

1
Sputum colour charts to guide antibiotic self-treatment of acute exacerbation of chronic obstructive pulmonary disease: the Colour-COPD RCT.用于指导慢性阻塞性肺疾病急性加重期抗生素自我治疗的痰液颜色图表:Colour-COPD随机对照试验
Health Technol Assess. 2025 May;29(28):1-42. doi: 10.3310/KPFD5558.
2
Detection of COPD exacerbations with continuous monitoring of breathing rate and inspiratory amplitude under oxygen therapy.在氧疗期间通过持续监测呼吸频率和吸气幅度来检测慢性阻塞性肺疾病急性加重
BMC Med Inform Decis Mak. 2025 Feb 25;25(1):101. doi: 10.1186/s12911-025-02939-3.
3
Early detection and prediction of acute exacerbation of chronic obstructive pulmonary disease.
慢性阻塞性肺疾病急性加重的早期检测与预测
Chin Med J Pulm Crit Care Med. 2023 Jun 2;1(2):102-107. doi: 10.1016/j.pccm.2023.04.004. eCollection 2023 Jun.
4
Characteristics of alpha-1 antitrypsin deficiency related lung disease exacerbations using a daily symptom diary and urinary biomarkers.使用每日症状日记和尿生物标志物描述 α-1 抗胰蛋白酶缺乏相关肺病加重的特征。
PLoS One. 2024 Feb 2;19(2):e0297125. doi: 10.1371/journal.pone.0297125. eCollection 2024.
5
The Experiences of Individuals with a History of Acute Exacerbations of COPD and Their Thoughts on Death: Empirical Qualitative Research.慢性阻塞性肺疾病急性加重病史患者的经历及其对死亡的看法:实证定性研究
Chronic Obstr Pulm Dis. 2023 Jul 26;10(3):259-269. doi: 10.15326/jcopdf.2023.0389.
6
Early diagnostic BioMARKers in exacerbations of chronic obstructive pulmonary disease: protocol of the exploratory, prospective, longitudinal, single-centre, observational MARKED study.慢性阻塞性肺疾病加重期的早期诊断生物标志物:探索性、前瞻性、纵向、单中心、观察性 MARKED 研究方案。
BMJ Open. 2023 Mar 3;13(3):e068787. doi: 10.1136/bmjopen-2022-068787.
7
Patient-Reported Outcome Measurements in Patients with COPD-Obstructive Sleep Apnea Overlap Syndrome: Time for Action?慢性阻塞性肺疾病-阻塞性睡眠呼吸暂停低通气综合征患者的患者报告结局测量:是采取行动的时候了吗?
J Pers Med. 2022 Nov 24;12(12):1951. doi: 10.3390/jpm12121951.
8
Different inhaled corticosteroid doses in triple therapy for chronic obstructive pulmonary disease: systematic review and Bayesian network meta-analysis.三联疗法治疗慢性阻塞性肺疾病中不同吸入性皮质类固醇剂量:系统评价和贝叶斯网络荟萃分析。
Sci Rep. 2022 Sep 20;12(1):15698. doi: 10.1038/s41598-022-18353-y.
9
Development and Validation of a Multivariable Prediction Model to Identify Acute Exacerbation of COPD and Its Severity for COPD Management in China (DETECT Study): A Multicenter, Observational, Cross-Sectional Study.开发和验证一种多变量预测模型,以识别中国 COPD 急性加重及其严重程度,用于 COPD 管理(DETECT 研究):一项多中心、观察性、横断面研究。
Int J Chron Obstruct Pulmon Dis. 2022 Sep 5;17:2093-2106. doi: 10.2147/COPD.S363935. eCollection 2022.
10
Towards precision in defining COPD exacerbations.迈向慢性阻塞性肺疾病加重定义的精准化。
Breathe (Sheff). 2021 Sep;17(3):210081. doi: 10.1183/20734735.0081-2021.